Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences

Provided By GlobeNewswire

Last update: Aug 27, 2025

BEDFORD, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific conferences in September 2025.